A new private-label deal will see Hologic Inc. distributing a soft tissue biopsy instrument manufactured by Angiotech Pharmaceuticals Inc.
Angiotech Pharmaceuticals Inc. (NSDQ:ANPI) inked a three-year, private-label deal with Bedford, Mass.-based Hologic Inc. (NSDQ:HOLX).
Under the terms of the agreement, Vancouver-based Angiotech will supply Hologic with its soft tissue biopsy device for breast biopsies. The deal is specific for products sold in the U.S. and will automatically renew after thee years, according to Angiotech.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The deal complements Hologic’s vacuum-assisted breast biopsy systems and expands its breast exam product offering with a “14g single-use, fully automatic biopsy instrument” with features including “a spring-loaded stylet and cannula, one-handed operation and an echogenic needle tip,”according to Angiotech.
There were approximately 1.8 million breast biopsies performed in the U.S. last year, according to Angiotech.
Last month Angiotech postponed payment of $9.7 million in interest on debt and a grappled with the possibility of de-listing from the NASDAQ stock exchange. The company also reported disappointing earnings for its 2010 third quarter, posting a net loss of $18.5 million, or 22 cents per diluted share, on sales of $59.0 million during the three months ended Sept. 30. That compares with a loss of $7.8 million, or 9 cents per diluted share, on sales of $63.2 million during the same period last year.
On Nov. 18 the company announced the sale of its Lifespan vascular graft business to LeMaitre Vascular Inc. (NSDQ:LMAT) for $3 million in November.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.
